Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer
Status:
Recruiting
Trial end date:
2027-07-01
Target enrollment:
Participant gender:
Summary
The study is being conducted to evaluate the safety, tolerability, pharmacokinetics,
radiation dosimetry, and preliminary efficacy of Lutetium Lu 177 JH020002 Injection in adult
patients with advanced prostate cancer.